Testing effectiveness (Phase 2)Looking for participantsNCT06189963
What this trial is testing
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Who this might be right for
Moderate Alzheimer Disease
NKGen Biotech, Inc. 36
Showing 20 of 0 results